RITUXIMAB

121280 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 21906
1 OFF LABEL USE 14989
2 RHEUMATOID ARTHRITIS 12611
3 PAIN 9729
4 FATIGUE 9288
5 DRUG INTOLERANCE 7196
6 ARTHRALGIA 7074
7 RASH 6928
8 INFUSION RELATED REACTION 6393
9 NAUSEA 6275
See all common reactions for RITUXIMAB

RITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2072 0.8022
1 SWOLLEN JOINT COUNT INCREASED 394 0.7710
2 RED BLOOD CELL SEDIMENTATION RATE 150 0.7538
3 PEMPHIGUS 4336 0.7347
4 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 291 0.6481
5 RHEUMATOID FACTOR POSITIVE 1607 0.6255
6 B-CELL LYMPHOMA RECURRENT 251 0.6122
7 GRANULOMA SKIN 358 0.6017
8 MANTLE CELL LYMPHOMA RECURRENT 128 0.5899
9 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 586 0.5762
See all enriched reactions for RITUXIMAB